bioRxiv Science⌕ Search

Biology subjects

Kearney, A. O.

Publications and source records attributed to Kearney, A. O..

2 recordsLinked to original sources

APOL1 G1 and G2 risk alleles modulate severity of diet-induced obesity in a transgenic mouse model

APOL1 G1 and G2 risk alleles are associated with an increased risk of chronic kidney disease. However, a causal relationship between these alleles and cardiometabolic traits has not been experimentally validated. To address this gap, we placed transgenic APOL1 G0, G1, and G2 FVB/NJ mice on a high-fat diet and analyzed them for weight gain as well as obesity-related cardiometabolic phenotypes. To test whether APOL1 risk alleles modulate the inflammatory basis of obesity, we also exposed bone marrow derived macrophages from these mice to pro-inflammatory, pro-hypertensive, and dyslipidemic conditions. APOL1 high-risk allele female mice gained fat mass more readily than their low-risk female counterparts, while APOL1 high-risk male mice gained fat mass less readily than low-risk males. A parallel sex difference was seen in expression of higher levels of Abca1, Hmox1, and Srebf1 in lipid-loaded female bone-marrow derived macrophages expressing G1 and G2 APOL1, along with minor differences in cardiac function. However, this finding occurred independently of hypertension and insulin resistance, and with only minor albuminuria. Thus, our results highlight the importance of sex as a biological variable in future APOL1 experiments.

genomics↗

G1 and G2 ApolipoproteinL1 modulate macrophage inflammation and lipid accumulation through the polyamine pathway

The G1 and G2 variants of the gene encoding Apolipoprotein L1 (APOL1) increase risk for kidney disease and cardiometabolic traits. While previous studies have elucidated key mechanisms by which G1 and G2 APOL1 cause cellular inflammation and cytotoxicity, it remains unclear whether these mechanisms drive inflammation in G1 and G2 macrophages. In this study, we used mouse bone-marrow-derived macrophages and human induced pluripotent stem cell-derived macrophages to identify altered immune signaling and inflammatory activation caused by G1 and G2 APOL1. We demonstrated that G1 and G2 APOL1 increased lipid accumulation, pro-inflammatory cytokine expression, and inflammasome signaling; this inflammatory response was sustained when treated with anti-inflammatory cytokines IL-4 and IL-10. Additionally, in G1 and G2 macrophages we observed increased mitochondrial size and elongation, oxidative phosphorylation, and glycolysis. Finally, we used unbiased metabolite analysis to identify an accumulation of polyamine spermidine and the enrichment of the spermidine synthesis pathway in G1 and G2 macrophages. When treated with polyamine inhibitor -difluoromethylornithine (DFMO), lipid accumulation and inflammasome gene expression decreased in G1 and G2 macrophages. Together, these findings establish the pro-inflammatory effects of G1 and G2 APOL1 in macrophages and identify a novel pathway which ameliorates G1 and G2 effects on cellular inflammation.

cell biology↗